Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer
Definitive chemoradiotherapy (CRT) is a cornerstone of treatment for locoregionally advanced head and neck cancer (HNC). Research is ongoing on how to improve the tumor response to treatment and limit normal tissue toxicity. A major limitation in that regard is the growing occurrence of intrinsic or...
Saved in:
Main Authors: | Tycho de Bakker, Anouk Maes, Tatiana Dragan, Philippe Martinive, Sébastien Penninckx, Dirk Van Gestel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/1/18 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radioresistance in rectal cancer: can nanoparticles turn the tide?
by: Diogo Coelho, et al.
Published: (2025-01-01) -
Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
by: Kai-Lin Yang, et al.
Published: (2025-02-01) -
Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
by: Shishi Yu, et al.
Published: (2025-02-01) -
Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients
by: Dominique A. Torozan, et al.
Published: (2025-01-01) -
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
by: Sharon Pei Yi Chan, et al.
Published: (2025-01-01)